Increase in the need for accurate disease diagnosis, growth in demand for personalized medicine, technological advancements in the field of metabolomics, and huge investments from the public and private sectors for R&D activities are anticipated to fuel the metabolomics market growth over the forecast period. Moreover, wide range of applications of metabolomics, increase in the prevalence of target diseases such as cancers, and increase in the scope of clinical trials and toxicological studies are boosting the metabolomics market. However, stringent regulatory guidelines, unavailability of advanced instruments, lack of technology adoption, dearth professional researchers, high cost for R&D activities, and issues with data examination and processing might hamper the growth of metabolomics services over the forecast period.
A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-metabolomics-services-market/#ulp-4H8Z4LpNMLEuOnnx
Metabolomics services market is segmented on the basis of product type, application, therapeutic area, and end-user
Based on the service type, metabolomics services market is segmented into the following:
Separation & Detection Services
Lipidomics
Proteomics
Targeted Metabolite Assays
Others
Bioinformatics Services
Based on the sample type, metabolomics services market is segmented into the following:
Urine
Tumour
Cell culture Media
Whole Blood
Food Ingredients
Plant
Others
Based on the sample source, metabolomics services market is segmented into the following:
Human
Animal
Others
Based on the end-user, metabolomics services market is segmented into the following:
Medical Industry
Agriculture Industry
Food Processing Industry
Others
Based on the region, metabolomics services market is segmented into the following:
North America
Europe
Asia-Pacific
Rest of the World
To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-metabolomics-services-market/#ulp-c654SbFYO64MsOhu
Metabolomics services market is growing at a significant CAGR owing to increase in the demand for personalized medicine and government initiations for the prevention of genetic disorders in new-born babies. Moreover, most of the pharmaceutical and biopharmaceutical companies are focusing on the R&D activities of metabolomics which are helping in the drug discovery, biomarker discovery, and other applications. Acquisitions & mergers, collaborations, and technological advancements are the strategies followed by the competitors for garnering the metabolomics market revenue. For instance, in August 2014, Cenix Bioscience GmbH inked an agreement with Metanomics Health GmbH for the development of metabolomic biomarkers. Moreover, in July 2017, Thermo Fisher Scientific collaborated with SRI international for the development of small molecule research.
Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-metabolomics-services-market/#ulp-14mlyhjMGhVjZqa3
Geographically, metabolomics services market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America estimated to hold large revenue share in global services market owing to a huge number of biopharmaceutical companies focusing on the R&D activities of metabolomics, rise in funding from the government organizations, and availability of professional researchers and well-established infrastructure in the region. Europe exhibiting significant growth due to high adoption of novel technologies, researchers and governments focusing on the prevention of genetic disorders, and increase in the target disease conditions are the factors drive the Europe metabolomics market over the forecast period. Moreover, due to increase in the population and birth rate, rise in the prevalence of diabetes and other targeted diseases, increase in R&D activities majorly in China, Japan, and India, and rise in demand for personalized medicine in Asia-Pacific region expected to create significant market opportunities over the forecast period.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-metabolomics-services-market/
Some of the players in metabolomics services market are Metanomics Health GmbH (Germany), Metabolon, Inc. (U.S.), SRI International (U.S.), Metabolomic discoveries GmbH (Germany), OWL Metabolomics (Spain), Sanyal biotechnology (U.S.) Cenix BioScience GmbH (Germany), West Coast Metabolomics Center (U.S), The Metabolomics Innovation Centre (TMIC) (Canada), Creative Proteomics (U.S), Lipotype GmbH (Germany), Stemina Biomarker Discovery, Inc. (U.S), Chenomx Inc. (Canada) to name a few
Increase in the need for accurate disease diagnosis growth in demand for personalized medicine technological advancements in the field of metabolomics and huge investments from the public and private sectors for R&amp;D activities are anticipated to fuel the metabolomics market growth over the forecast period Moreover wide range of applications of metabolomics increase in the prevalence of target diseases such as cancers and increase in the scope of clinical trials and toxicological studies are boosting the metabolomics market However stringent regulatory guidelines unavailability of advanced instruments lack of technology adoption dearth professional researchers high cost for R&amp;D activities and issues with data examination and processing might hamper the growth of metabolomics services over the forecast period A sample of this report is available upon request @ https://www.precisionbusinessinsights.com/market-reports/global-metabolomics-services-market/#ulp-4H8Z4LpNMLEuOnnx Metabolomics services market is segmented on the basis of product type application therapeutic area and end-user Based on the service type metabolomics services market is segmented into the following Separation &amp; Detection Services Lipidomics Proteomics Targeted Metabolite Assays Others Bioinformatics Services Based on the sample type metabolomics services market is segmented into the following Urine Tumour Cell culture Media Whole Blood Food Ingredients Plant Others Based on the sample source metabolomics services market is segmented into the following Human Animal Others Based on the end-user metabolomics services market is segmented into the following Medical Industry Agriculture Industry Food Processing Industry Others Based on the region metabolomics services market is segmented into the following North America Europe Asia-Pacific Rest of the World To view TOC of this report is available upon request @ https://www.precisionbusinessinsights.com/market-reports/global-metabolomics-services-market/#ulp-c654SbFYO64MsOhu Metabolomics services market is growing at a significant CAGR owing to increase in the demand for personalized medicine and government initiations for the prevention of genetic disorders in new-born babies Moreover most of the pharmaceutical and biopharmaceutical companies are focusing on the R&amp;D activities of metabolomics which are helping in the drug discovery biomarker discovery and other applications Acquisitions &amp; mergers collaborations and technological advancements are the strategies followed by the competitors for garnering the metabolomics market revenue For instance in August 2014 Cenix Bioscience GmbH inked an agreement with Metanomics Health GmbH for the development of metabolomic biomarkers Moreover in July 2017 Thermo Fisher Scientific collaborated with SRI international for the development of small molecule research Need more information about this report @ https://www.precisionbusinessinsights.com/market-reports/global-metabolomics-services-market/#ulp-14mlyhjMGhVjZqa3 Geographically metabolomics services market is segmented into North America Europe Asia-Pacific and Rest of the World North America estimated to hold large revenue share in global services market owing to a huge number of biopharmaceutical companies focusing on the R&amp;D activities of metabolomics rise in funding from the government organizations and availability of professional researchers and well-established infrastructure in the region Europe exhibiting significant growth due to high adoption of novel technologies researchers and governments focusing on the prevention of genetic disorders and increase in the target disease conditions are the factors drive the Europe metabolomics market over the forecast period Moreover due to increase in the population and birth rate rise in the prevalence of diabetes and other targeted diseases increase in R&amp;D activities majorly in China Japan and India and rise in demand for personalized medicine in Asia-Pacific region expected to create significant market opportunities over the forecast period Get access to full summary @ https://www.precisionbusinessinsights.com/market-reports/global-metabolomics-services-market/ Some of the players in metabolomics services market are Metanomics Health GmbH Germany Metabolon, Inc. U.S. SRI International U.S. Metabolomic discoveries GmbH Germany OWL Metabolomics Spain Sanyal biotechnology U.S. Cenix BioScience GmbH Germany West Coast Metabolomics Center U . S The Metabolomics Innovation Centre TMIC Canada Creative Proteomics U . S Lipotype GmbH Germany Stemina Biomarker Discovery, Inc. U . S Chenomx Inc. Canada to name a few